Zobrazeno 1 - 10 of 264 pro vyhledávání: '"DW Beelen"'
1
Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation
Autor: DW Beelen, E Haralambie, H Brandt, G Linzenmeier, KD Muller, K Quabeck, HG Sayer, U Graeven, HK Mahmoud, UW Schaefer
Publikováno v: Blood. 80:2668-2676
The influence of intestinal bacterial decontamination on the occurrence of grades II to IV acute graft-versus-host disease (GVHD) was retrospectively analyzed in 194 predominantly adult patients treated by genotypically identical sibling marrow trans
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c828d8a4450f8dbc0e17cafa4c11d0be
https://doi.org/10.1182/blood.v80.10.2668.bloodjournal80102668
Zobrazit plný text záznamu
3
Acute toxicity and first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia [see comments]
Autor: DW Beelen, K Quabeck, U Graeven, HG Sayer, HK Mahmoud, UW Schaefer
Publikováno v: Blood. 74:1507-1516
The combination of high-dose busulfan (16 mg/kg) and 200 mg/kg cyclophosphamide is gaining increasing significance as a preparative regimen prior to autologous, syngeneic, or allogeneic marrow transplantation. A new regimen of high-dose busulfan in c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::36d864221cb8f189c150489887d785a1
https://doi.org/10.1182/blood.v74.5.1507.bloodjournal7451507
Zobrazit plný text záznamu
4
Akademický článek
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison.
Autor: Beelen DW; Department of Haematology and Stem Cell Transplantation, West German Cancer Center, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany. dietrich.beelen@uk-essen.de., Iacobelli S; Department of Biology, University Tor Vergata of Rome, Rome, Italy., Koster L; EBMT Data Office Leiden, Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, Netherlands., Eikema DJ; EBMT Data Office Leiden, Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, Netherlands., van Biezen A; EBMT Data Office Leiden, Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, Netherlands., Stölzel F; Division of Stem Cell Transplantation and Cellular Immunotherapies, Department of Internal Medicine 2, University Hospital Schleswig-Holstein, Kiel, Kiel University, Kiel, Germany.; Faculty of Medicine Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Ciceri F; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Bethge W; Department of Hematology and Oncology, University Hospital Tübingen, Tübingen, Germany., Dreger P; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany., Wagner-Drouet EM; Third Department of Medicine - Hematology, Internal Oncology & Pneumology, Johannes Gutenberg-University Medical Center, Mainz, Germany., Reményi P; St. István and St. László Hospital of Budapest, Budapest, Hungary., Stelljes M; Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany., Markiewicz M; Department of Hematology, Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, Rzeszow, Poland., McLornan DP; University College London Hospital, London, UK., Yakoub-Agha I; Centre Hospitalier Universitaire de Lille, Université Lille, INSERM U1286, Infinite, Lille, France., Mohty M; Hospital Saint-Antoine, Sorbonne Université, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2024 May; Vol. 59 (5), pp. 670-679. Date of Electronic Publication: 2024 Feb 21.
Zobrazit plný text záznamu
5
Akademický článek
Patterns of follow-up care in adult blood cancer survivors-Prospective evaluation of health-related outcomes, resource use, and quality of life.
Autor: Lax H; Institut für Medizinische Informatik, Biometrie und Epidemiologie, Universität Duisburg-Essen, Essen, Germany., Baum J; Klinik für Hämatologie, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Germany., Lehmann N; Institut für Medizinische Informatik, Biometrie und Epidemiologie, Universität Duisburg-Essen, Essen, Germany., Merkel-Jens A; Institut für Medizinische Informatik, Biometrie und Epidemiologie, Universität Duisburg-Essen, Essen, Germany., Beelen DW; Klinik für Knochenmarktransplantation, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Germany., Jöckel KH; Institut für Medizinische Informatik, Biometrie und Epidemiologie, Universität Duisburg-Essen, Essen, Germany., Dührsen U; Klinik für Hämatologie, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Germany.
Publikováno v: Cancer medicine [Cancer Med] 2024 Apr; Vol. 13 (7), pp. e7095.
Zobrazit plný text záznamu
6
Akademický článek
Health-Related Complications during Follow-Up and Their Impact on Blood Cancer Survivors: Results from the "Aftercare in Blood Cancer Survivors" (ABC) Study.
Autor: Baum J; Klinik für Hämatologie, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Germany., Lax H; Institut für Medizinische Informatik, Biometrie und Epidemiologie, Universität Duisburg-Essen, Essen, Germany., Lehmann N; Institut für Medizinische Informatik, Biometrie und Epidemiologie, Universität Duisburg-Essen, Essen, Germany., Merkel-Jens A; Institut für Medizinische Informatik, Biometrie und Epidemiologie, Universität Duisburg-Essen, Essen, Germany., Beelen DW; Klinik für Knochenmarktransplantation, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Germany., Jöckel KH; Institut für Medizinische Informatik, Biometrie und Epidemiologie, Universität Duisburg-Essen, Essen, Germany., Dührsen U; Klinik für Hämatologie, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Germany.
Publikováno v: Acta haematologica [Acta Haematol] 2024; Vol. 147 (4), pp. 435-446. Date of Electronic Publication: 2024 Jan 16.
Zobrazit plný text záznamu
7
Akademický článek
A dynamic time-to-event model for prediction of acute graft-versus-host disease in patients after allogeneic hematopoietic stem cell transplantation.
Autor: Och K; Department of Clinical Pharmacy, Saarland University, Saarbrücken, Germany., Turki AT; Department of Hematology and Stem Cell Transplantation, West-German Cancer Center, University Hospital Essen, Essen, Germany., Götz KM; Department of Clinical Pharmacy, Saarland University, Saarbrücken, Germany., Selzer D; Department of Clinical Pharmacy, Saarland University, Saarbrücken, Germany., Brossette C; Department of Pediatric Oncology and Hematology, Saarland University, Homburg, Germany., Theobald S; Department of Pediatric Oncology and Hematology, Saarland University, Homburg, Germany., Braun Y; Department of Pediatric Oncology and Hematology, Saarland University, Homburg, Germany., Graf N; Department of Pediatric Oncology and Hematology, Saarland University, Homburg, Germany., Rauch J; Department of Biomedical Data & Bioethics, Fraunhofer Institute for Biomedical Engineering (IBMT), Sulzbach, Germany., Rohm K; Department of Biomedical Data & Bioethics, Fraunhofer Institute for Biomedical Engineering (IBMT), Sulzbach, Germany., Weiler G; Department of Biomedical Data & Bioethics, Fraunhofer Institute for Biomedical Engineering (IBMT), Sulzbach, Germany., Kiefer S; Department of Biomedical Data & Bioethics, Fraunhofer Institute for Biomedical Engineering (IBMT), Sulzbach, Germany., Schwarz U; Institute for Formal Ontology and Medical Information Science, Saarland University, Saarbrücken, Germany., Eisenberg L; Department of Computer Science, University of Tübingen, Tübingen, Germany., Pfeifer N; Department of Computer Science, University of Tübingen, Tübingen, Germany., Ihle M; Averbis GmbH, Freiburg, Germany., Grandjean A; Averbis GmbH, Freiburg, Germany., Fix S; Averbis GmbH, Freiburg, Germany., Riede C; Averbis GmbH, Freiburg, Germany., Rissland J; Institute of Virology, Saarland University Medical Centre, Homburg, Germany., Smola S; Institute of Virology, Saarland University Medical Centre, Homburg, Germany.; Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University Campus, Saarbrücken, Germany., Beelen DW; Department of Hematology and Stem Cell Transplantation, West-German Cancer Center, University Hospital Essen, Essen, Germany., Kaddu-Mulindwa D; Department of Internal Medicine 1, University Hospital of the Saarland, Homburg, Germany., Bittenbring J; Department of Internal Medicine 1, University Hospital of the Saarland, Homburg, Germany., Lehr T; Department of Clinical Pharmacy, Saarland University, Saarbrücken, Germany.
Publikováno v: Cancer medicine [Cancer Med] 2024 Jan; Vol. 13 (1), pp. e6833. Date of Electronic Publication: 2023 Dec 22.
Zobrazit plný text záznamu
8
Akademický článek
Impairment of vocational activities and financial problems are frequent among German blood cancer survivors.
Autor: Baum J; Klinik für Hämatologie, Universitätsklinikum Essen, Universität Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany., Lax H; Institut für Medizinische Informatik, Biometrie und Epidemiologie, Universität Duisburg-Essen, Essen, Germany., Lehmann N; Institut für Medizinische Informatik, Biometrie und Epidemiologie, Universität Duisburg-Essen, Essen, Germany., Merkel-Jens A; Institut für Medizinische Informatik, Biometrie und Epidemiologie, Universität Duisburg-Essen, Essen, Germany., Beelen DW; Klinik für Knochenmarktransplantation, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Germany., Jöckel KH; Institut für Medizinische Informatik, Biometrie und Epidemiologie, Universität Duisburg-Essen, Essen, Germany., Dührsen U; Klinik für Hämatologie, Universitätsklinikum Essen, Universität Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany. ulrich.duehrsen@uk-essen.de.
Publikováno v: Scientific reports [Sci Rep] 2023 Dec 21; Vol. 13 (1), pp. 22856. Date of Electronic Publication: 2023 Dec 21.
Zobrazit plný text záznamu
9
Akademický článek
Data-driven grading of acute graft-versus-host disease.
Autor: Bayraktar E; Computational Hematology Lab, West-German Cancer Center, University Hospital Essen, Hufelandstr. 55, 45122, Essen, Germany.; Department of Hematology and Stem Cell Transplantation, West-German Cancer Center, University Hospital Essen, Hufelandstr. 55, 45122, Essen, Germany.; Chair III of Applied Mathematics, TU Dortmund University of Applied Sciences, Vogelpothsweg 87, 44227, Dortmund, Germany., Graf T; Computational Hematology Lab, West-German Cancer Center, University Hospital Essen, Hufelandstr. 55, 45122, Essen, Germany.; Department of Hematology and Stem Cell Transplantation, West-German Cancer Center, University Hospital Essen, Hufelandstr. 55, 45122, Essen, Germany., Ayuk FA; Department for Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf (UKE), Martinistraße 52, 20251, Hamburg, Germany., Beutel G; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany., Penack O; Department of Hematology, Oncology and Tumorimmunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany., Luft T; Department of Internal Medicine V, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany., Brueder N; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany., Castellani G; Department of Medical and Surgical Sciences- DIMEC, Applied Physics and Biophysics group, University of Bologna, Via Zamboni 33, 40126, Bologna, Italy., Reinhardt HC; Department of Hematology and Stem Cell Transplantation, West-German Cancer Center, University Hospital Essen, Hufelandstr. 55, 45122, Essen, Germany.; German Cancer Consortium (DKTK), Partner sites Essen/Düsseldorf, Hufelandstr. 55, 45122, Essen, Germany.; Cancer Research Center Cologne Essen (CCCE), Partner site Essen, Hufelandstr. 55, 45122, Essen, Germany., Kröger N; Department for Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf (UKE), Martinistraße 52, 20251, Hamburg, Germany., Beelen DW; Department of Hematology and Stem Cell Transplantation, West-German Cancer Center, University Hospital Essen, Hufelandstr. 55, 45122, Essen, Germany.; German Cancer Consortium (DKTK), Partner sites Essen/Düsseldorf, Hufelandstr. 55, 45122, Essen, Germany., Turki AT; Computational Hematology Lab, West-German Cancer Center, University Hospital Essen, Hufelandstr. 55, 45122, Essen, Germany. amin.turki@uk-essen.de.; Department of Hematology and Stem Cell Transplantation, West-German Cancer Center, University Hospital Essen, Hufelandstr. 55, 45122, Essen, Germany. amin.turki@uk-essen.de.; German Cancer Consortium (DKTK), Partner sites Essen/Düsseldorf, Hufelandstr. 55, 45122, Essen, Germany. amin.turki@uk-essen.de.; Cancer Research Center Cologne Essen (CCCE), Partner site Essen, Hufelandstr. 55, 45122, Essen, Germany. amin.turki@uk-essen.de.; Department of Hematology and Oncology, Marienhospital University Hospital, Ruhr-University Bochum, Universitätsstr. 150, 44801, Bochum, Germany. amin.turki@uk-essen.de.; Institute for Experimental Cellular Therapy, University Hospital Essen, Hufelandstr. 55, 45122, Essen, Germany. amin.turki@uk-essen.de.
Publikováno v: Nature communications [Nat Commun] 2023 Nov 28; Vol. 14 (1), pp. 7799. Date of Electronic Publication: 2023 Nov 28.
Zobrazit plný text záznamu
10
Akademický článek
Population pharmacokinetic modeling of treosulfan and rationale for dose recommendation in children treated for conditioning prior to allogeneic hematopoietic stem cell transplantation.
Autor: Li X; medac GmbH, Theaterstraße 6, 22880, Wedel, Germany. Electronic address: x.li@medac.de., Kalwak K; Wroclaw Medical University, Department of Pediatric Hematology, Oncology and Bone Marrow Transplantation, Wybrzeze Ludwika Pasteura 1, 50-367, Wroclaw, Poland., Beier R; Hannover Medical School, Department of Paediatric Haematology and Oncology, Carl-Neuberg-Straße 1, 30625, Hannover, Germany., Kehne J; medac GmbH, Theaterstraße 6, 22880, Wedel, Germany., Möller AK; medac GmbH, Theaterstraße 6, 22880, Wedel, Germany., Baumgart J; medac GmbH, Theaterstraße 6, 22880, Wedel, Germany., Beelen DW; University Hospital Essen, Department of Haematology and Stem Cell Transplantation, West-German Cancer Centre, Hufelandstraße 55, 45147, Essen, Germany., Hilger RA; University Hospital Essen, West-German Cancer Center, Department of Medical Oncology, Hufelandstraße 55, 45147, Essen, Germany., Vora A; Great Ormond Street Hospital for Children NHS Foundation, Great Ormond Street, WC1N 3JH, London, United Kingdom., Sykora KW; Hannover Medical School, Department of Paediatric Haematology and Oncology, Carl-Neuberg-Straße 1, 30625, Hannover, Germany.
Publikováno v: Drug metabolism and pharmacokinetics [Drug Metab Pharmacokinet] 2023 Oct; Vol. 52, pp. 100515. Date of Electronic Publication: 2023 May 30.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje